Please login to the form below

Not currently logged in
Email:
Password:

venetoclax

This page shows the latest venetoclax news and features for those working in and with pharma, biotech and healthcare.

Roche, AbbVie hit by clinical hold for Venclexta in myeloma

Roche, AbbVie hit by clinical hold for Venclexta in myeloma

say they “remain confident in the benefit/risk profile of venetoclax in [its] approved indications.”. ... a specific biomarker that in early trials seem to be strong responders to venetoclax.

Latest news

More from news
Approximately 15 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    The FDA also approved AbbVie and Roche’s Venclexta (venetoclax) with cytarabine or a hypomethylating agent (azacitidine or decitabine) for the exact same indication – adding to the options for this patient

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics